| Taxfree & Taxable bonds Retail NCD Reckoner by HDFC Securities | |
| Company: | Taxfree & Taxable bonds Retail NCD Reckoner |
| Brokerage: | HDFC Sec |
| Date of report: | December 16, 2022 |
| Type of Report: | Techno-Funda |
| Recommendation: | Buy |
| Upside Potential: | 9.27% |
| Summary: | In Tax Free Bonds, to avail (or retain) the 25bps additional in the coupon rate, Investors should be aware that the total investment in the aggregate face value of Bonds held by the Bondholders in all the Series of Bonds, allotted under the relevant Tranche Issue shall be clubbed and taken together and that should be up to Rs. 10 Lakhs |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Taxfree & Taxable bonds Retail NCD Reckoner |
| Top 9 Techno-Funda Stock Picks for CY23 by ICICI Direct | |
| Company: | Model Portfolio |
| Brokerage: | ICICI-Direct |
| Date of report: | December 20, 2022 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | History does not repeat but it rhymes: Indian equities are likely to display the same rhythm that the US and Nikkei did in 1990-2000 and 1980-1990, respectively, i.e. delivering a decadal move of 5x on headline indices. Our prognosis of various Technical studies leads us to the conclusion that the Nifty is poised to reach towards 50000 by CY30. More so, the performance of 2021 and 2022 further adds strength to our argument given the Nifty is mimicking our forecast trajectory. What is more exciting is that we are entering 2023, which, as per decadal studies, has turned out to be a strong year |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | ICICI-Direct, Model Portfolio |
| GAIL’s Valuations remain overly pessimistic and ignore the solid business model and strong long-term prospects: ICICI Securities | |
| Company: | GAIL |
| Brokerage: | ICICI Securities |
| Date of report: | December 20, 2022 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 30% |
| Summary: | We value GAIL on the basis of FY24E EV/EBITDA multiples of 4-5.5x applied to various segments, leading to a target price of Rs127/sh (implying 30% upside). Current valuations of 6.3x FY24E EPS and 5.3x FY24E EV/EBITDA remain well below 5-year valuation bands. Even at our target price, P/E of 8.2x FY24E EPS, and |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | GAIL, ICICI Securities |
| Indian Hotels is rapid scaling up margin-accretive new businesses. Buy for target price of Rs 390: Motilal Oswal | |
| Company: | Indian Hotels |
| Brokerage: | Motilal Oswal |
| Date of report: | December 19, 2022 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 19% |
| Summary: | Indian Hotel’s (IH’s) new and re-imagined businesses Ama Stays, Qmin, Chambers, and Management contracts are expected to scale up rapidly on the lower base and high growth runway. These businesses are margin accretive with higher margin flowthrough, thereby driving up the RoCE. The new business is expected to contribute ~26% to the company’s operating profits by FY25. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Indian Hotels, Motilal Oswal |
| JB Chemicals is the preferred pick in the Pharma sector: Nirmal Bang | |
| Company: | JB Chem |
| Brokerage: | Nirmal Bang |
| Date of report: | December 18, 2022 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 15.2% |
| Summary: | JB Chem has 7 formulations facilities and 1 API facility with most of the units approved by all major compliance agencies, including units TI10 (OSD), T20 (OSD) and D9 (API), which are USFDA compliant as well. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | JB Chem, Nirmal Bang |
| PCBL Ltd is a carbon black giant, set to grow at a fast clip. Buy for 35% upside: SMIFS | |
| Company: | PCBL |
| Brokerage: | SMIFS |
| Date of report: | December 18, 2022 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 35% |
| Summary: | Currently, the stock is trading at inexpensive valuation on FY25E P/E of ~9.3x. We value the stock on forward P/E multiple of 12.5x owing to increasing share of speciality business, robust volume growth & rising exports share and, thereby, arrive at target price of Rs 183 per share which offers upside of 35% from current valuations. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | PCBL, SMIFS |
| Worst is behind Balrampur Chini. Buy for Target Price of Rs 465 (21.6% Upside) | |
| Company: | balrampur chini |
| Brokerage: | jmfics |
| Date of report: | December 15, 2022 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 21.6% |
| Summary: | We remain positive on the sugar sector (especially efficient companies) as government policies (sugarcane price/MSP/ethanol prices) will ensure survival of the weakest. While the regulation of sugar exports appears optically negative, we are convinced that it is aimed at a) ensuring adequate stock for local consumption, thus avoiding any undesired rally in domestic prices, and b) continuity in the ethanol programme (ethanol momentum could get upset in case of a significant rally in sugar prices). BRCM continues to be the best among the sugar pack, in our view. We maintain BUY rating on Balrampur Chini (CMP-INR 374; Sep’23TP- INR 465). |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | balrampur chini, jm, jmfics |
| Long Term Recommendation Carysil Ltd. Buy for target price of Rs 784 (59% upside) | |
| Company: | Acrysil, Carysil |
| Brokerage: | Edelweiss |
| Date of report: | December 13, 2022 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 59% |
| Summary: | Carysil is well-placed for strong growth, supported by industry tailwinds, increased home improvement spending and demand for aesthetically appealing products globally. Although we saw earnings moderation in FY23 on high quartz sink inventories in the channel, we expect revenue growth to recover sharply in FY24E |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Acrysil, Carysil, Edelweiss |
| Investors’ Presentation of Likhitha Infrastructure (Ashish Kacholia’s Portfolio stock) | |
| Company: | Likhitha Infrastructure |
| Brokerage: | |
| Date of report: | December 1, 2022 |
| Type of Report: | Investors' Presentation |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | High Revenue and Profit Growth with High Return on Capital Deployed (ROCE) and Low PE ratio |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Likhitha Infrastructure |
| MOTILAL OSWAL 27th ANNUAL WEALTH CREATION STUDY (2017-2022) | |
| Company: | Motilal Oswal, Wealth Creation Study |
| Brokerage: | Motilal Oswal |
| Date of report: | December 9, 2022 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | The Financial sector, coming out of Covid despair, is likely to dominate Wealth Creation in the foreseeable future |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Motilal Oswal 27th Annual Wealth Creation Study |